You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Angiotensin receptor II antagonist

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Covid19, Angiotensin II Receptor Antagonist Adverse Reaction Trial in São Paulo (Renin-angiotensin system inhibitors)

Terminated
  • Covid19
  • Angiotensin II Receptor Antagonist Adverse Reaction
  • Renin-angiotensin system inhibitors
  • São Paulo, SP, Brazil
    Instituto do Coração - Incor HCFMUSP
Sep 28, 2021

Coronavirus Disease(COVID)-19 Acute Respiratory Distress

Recruiting
  • COVID
  • Acute Respiratory Distress Syndrome
  • Angiotensin II
  • Interleukin-1 receptor antagonist
  • London, United Kingdom
    Guy's & St Thomas' Hospital
Aug 3, 2021

Aortic Valve Stenosis, Valsartan, Angiotensin Receptor Antagonists Trial in Limoges (Valsartan, Placebo Oral Tablet)

Not yet recruiting
  • Aortic Valve Stenosis
  • +5 more
  • Limoges, France
    Limoges university hospital
Dec 23, 2022

Coarctation of Aorta, High Blood Pressure Trial in Rochester (Losartan, Amlodipine, Placebo)

Not yet recruiting
  • Coarctation of Aorta
  • High Blood Pressure
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Nov 21, 2023

Therapeutic Drug Use for CKD Patients

Active, not recruiting
  • Chronic Kidney Disease
  • angiotensin converting enzyme inhibitors, angiotensin II receptor blockers, DPP-4 inhibitors, GLP-1 receptor agonists, SGLT2 inhibitors, calcium channel blockers, β Receptor blocker
  • Jinan, Shandong, China
    Xiao Li，MD
Apr 18, 2023

COVID-19, SARS-CoV2 Infection Trial in India (Candesartan Cilexetil, Repagermanium, Candesartan Placebo)

Recruiting
  • COVID-19
  • SARS-CoV2 Infection
  • Candesartan Cilexetil
  • +3 more
  • Guntur, India
  • +4 more
Mar 13, 2022

Diabetic Kidney Disease Trial in Australia (SER150, Placebo)

Recruiting
  • Diabetic Kidney Disease
  • Liverpool, New South Wales, Australia
  • +6 more
May 17, 2022

Prostate Cancer, Prostate Adenocarcinoma Trial (drug, other, procedure)

Not yet recruiting
  • Prostate Cancer
  • Prostate Adenocarcinoma
  • (no location specified)
Feb 2, 2023

Preeclampsia Postpartum Trial in Iowa City (Losartan Potassium, Placebo)

Recruiting
  • Preeclampsia Postpartum
  • Losartan Potassium
  • Placebo
  • Iowa City, Iowa
    University of Iowa
May 16, 2022

Cardiovascular Diseases, Hypertension Trial in San Francisco (Losartan, Placebo)

Recruiting
  • Cardiovascular Diseases
  • Hypertension
  • San Francisco, California
    San Francisco Veterans' Affairs Medical Center
Apr 29, 2022

Kidney Disease Trial in United States (Bremelanotide, RAAS inhibition therapy)

Recruiting
  • Kidney Disease
  • Chula Vista, California
  • +5 more
Jan 23, 2023

Pulmonary Hypertension Trial in Badalona (Sacubitril / Valsartan Oral Tablet [Entresto])

Completed
  • Pulmonary Hypertension
  • Sacubitril / Valsartan Oral Tablet [Entresto]
  • Badalona, Barcelona, Spain
    Germans Trias i Pujol University Hospital
Sep 23, 2021

COVID-19, Cardiovascular Diseases Trial in Brazil, Canada, Mexico (Angiotensin converting enzyme inhibitor, Angiotensin II

Recruiting
  • COVID-19
  • Cardiovascular Diseases
  • Angiotensin converting enzyme inhibitor
  • Angiotensin II Receptor Blockers
  • Maceio, Alagoas, Brazil
  • +30 more
Jan 13, 2023

Rectal Cancer Trial in New York (Etrumadenant (AB928), Radiation therapy, FOLFOX regimen)

Recruiting
  • Rectal Cancer
  • Etrumadenant (AB928)
  • +3 more
  • New York, New York
  • +2 more
Apr 10, 2022

Plasma Angiotensin II and Angiotensin II Receptor Levels in

Active, not recruiting
  • Sepsis
  • Septic Shock
    • Malatya, Turkey
      Ayse Belin B OZER
    Jan 16, 2021

    Breast Cancer, Tumor, Breast, Breast Diseases Trial in Poland (Sacubitril-valsartan)

    Not yet recruiting
    • Breast Cancer
    • +12 more
    • Opole, Opolskie, Poland
    • +3 more
    Jul 15, 2022

    Idiopathic Membranous Nephropathy Trial in Paris (symptomatic treatment (Converting Enzyme inhibitor, Angiotensin II,

    Completed
    • Idiopathic Membranous Nephropathy
    • symptomatic treatment (Converting Enzyme inhibitor, Angiotensin II, Anti-renin, Aldosterone antagonist diuretic, Beta blocker, Calcium inhibitor, statin)
    • experimental (Non Immunosuppressive Symptomatic Treatment (NIST) and Rituximab)
    • Paris, France
      Department of Nephrology , Tenon hospital - APHP
    Oct 18, 2021

    Intracerebral Haemorrhage Trial in Manchester (IL-1Ra Kineret®, IL-1Ra Placebo)

    Completed
    • Intracerebral Haemorrhage
    • IL-1Ra Kineret®
    • IL-1Ra Placebo
    • Manchester, North West, United Kingdom
      Salford Royal NHS Foundation Trust
    Oct 4, 2021

    Heart Failure Trial in Saga (Sacubitril Valsartan Sodium Hydrate, Standard treatment)

    Recruiting
    • Heart Failure
    • Sacubitril Valsartan Sodium Hydrate
    • Standard treatment
    • Saga, Japan
      Saga University Hospital
    Dec 27, 2021

    End-Stage Renal Disease Trial in United States (Anakinra, Placebo)

    Completed
    • End-Stage Renal Disease
    • Washington, District of Columbia
    • +3 more
    Jan 19, 2022

    STEMI - ST Elevation Myocardial Infarction, Left Ventricular Systolic Dysfunction Trial (Dapagliflozin 10Mg Tab, Placebo)

    Not yet recruiting
    • STEMI - ST Elevation Myocardial Infarction
    • Left Ventricular Systolic Dysfunction
    • Dapagliflozin 10Mg Tab
    • Placebo
    • (no location specified)
    Sep 6, 2021

    Idiopathic Membranous Nephropathy Trial in Aarhus (100 mg AP1189, Placebo)

    Recruiting
    • Idiopathic Membranous Nephropathy
    • 100 mg AP1189
    • Placebo
    • Aarhus, Denmark
      Aarhus Universitetshospital
    Sep 21, 2021

    Heart Failure With Reduced Ejection Fraction Trial in Los Angeles (Email Nudge)

    Not yet recruiting
    • Heart Failure With Reduced Ejection Fraction
    • Email Nudge
    • Los Angeles, California
      University of California, Los Angeles
    Apr 7, 2023

    SARS-CoV-2, COVID-19 Trial in Austria, Germany (ACE inhibitor, angiotensin receptor blocker)

    Completed
    Has Results
    • SARS-CoV-2
    • COVID-19
    • ACE inhibitor, angiotensin receptor blocker
    • Innsbruck, Tyrol, Austria
    • +30 more
    Aug 18, 2022

    Cognitively Normal Older Adults, Hypertension, Subjective Cognitive Decline Trial in Dallas (Angiotensin II Receptor Blockers

    Recruiting
    • Cognitively Normal Older Adults
    • +3 more
    • Angiotensin II Receptor Blockers (ARBs, losartan) and Calcium Channel Blockers (CCB, amlodipine)
    • PCP
    • Dallas, Texas
      University of Texas Southwestern Medical Center
    Dec 1, 2022